欢迎访问浙江中西医结合杂志   今天是   加入收藏   |   设为首页
褚蕴.何氏补肾益气活血汤对ACA阳性血栓前状态RSA小鼠母胎界面 JAK/STAT3信号通路的影响[J].浙江中西医结合杂志,2025,35(8):
何氏补肾益气活血汤对ACA阳性血栓前状态RSA小鼠母胎界面 JAK/STAT3信号通路的影响
Effect of Heshi Bushen Yiqi Huoxue Decoction on regulating status of maternal-fetal interface in RSA mice suffering ACA positive prethrombus status based on JAK ∕ STAT3 signaling pathway
投稿时间:2025-04-08  修订日期:2025-06-24
DOI:
中文关键词:  抗心磷脂抗体;复发性流产;母胎界面;JAK/STAT3信号通路;何氏补肾益气活血汤  小鼠
英文关键词:Anticardiolipin Antibody  Recurrent Spontaneous Abortion  Maternal-Fetal Interface  JAK∕STAT3 Signaling Pathway  Heshi Bushen Yiqi Huoxue Decoction  Mice
基金项目:浙江省中医药科技计划项目(No.2022ZA099);杭州市科技发展计划项目(No.202004A13);浙江中医药重点学科建设项目(2024-XK-54)
作者单位E-mail
褚蕴* 杭州市中医院 380139366@qq.com 
摘要点击次数: 170
全文下载次数: 0
中文摘要:
      目的 本研究旨在通过构建动物实验模型探讨何氏补肾益气活血方对抗心磷脂抗体(ACA)阳性血栓前状态复发性流产(RSA)的干预效应,并基于酪氨酸蛋白激酶/信号转导子和转录激活子3(JAK/STAT3)信号传导途径阐明其可能的作用机制。方法 采用人源β2-糖蛋白Ⅰ(β2-GPⅠ)构建ACA阳性RSA小鼠模型。随机将50只复发性流产小鼠分为空白对照(生理盐水干预)、模型对照(β2-GPⅠ处理)、阳性对照(阿司匹林治疗)及何氏补肾益气活血方低/高剂量治疗组,每组10只。从妊娠第1天开始灌胃给药,干预14天。处死小鼠,留取样本,测定胚胎吸收率。通过酶联免疫吸附法(ELISA)定量分析外周血ACA水平;应用免疫组化检测母胎界面(胎盘及蜕膜)非受体酪氨酸蛋白激酶(JAK)、糖蛋白130(GP130)、磷酸化信号转导子与转录激活子3(p-STAT3)及增殖细胞核抗原(PCNA)表达;采用蛋白质印迹法(Western blot)定量分析母胎界面STAT3磷酸化水平。结果 与模型组相比,何氏补肾益气活血方低、高剂量组及阿司匹林组胚胎丢失率[(24.49±11.17)%、(16.18±11.92)%、(15.94±8.01)%比(42.53±15.12)%,P<0.05]显著降低,血清ACA滴度[(93.16±6.75)pg/mL、(92.31±5.22)pg/mL、(81.60±5.18)pg/mL比(419.51±94.00)pg/mL,P<0.05]下降幅度具有统计学差异。与模型组相比,何氏补肾益气活血方低、高剂量组及阿司匹林组母胎界面胎盘JAK[(1.44±0.53)、(1.43±0.50)、(1.51±0.35)比(0.21±0.31),P<0.05]、胎盘p-STAT3[(1.83±0.41)、(2.00±0.63)、(2.00±0.71)比(0.20±0.45),P<0.05]、蜕膜p-STAT3[(1.50±0.54)、(2.13±0.42)、(1.80±0.65)比(0.40±0.38),P<0.05]、胎盘PCNA[(2.50±0.55)、(2.67±0.52)、(2.80±0.84)比(1.39±0.99),P<0.05]及蜕膜PCNA[(2.88±0.36)、(3.00±0.58)、(2.91±0.68)比(3.50±0.59),P<0.05]表达显著上调。何氏补肾益气活血方低、高剂量组及阿司匹林组蜕膜及胎盘p-STAT3/STAT3蛋白表达的灰度积比值[(1.05±0.08)、(1.05±0.07)、(1.06±0.09)比(1.06±0.09),P<0.05]、[(1.07±0.09)、(1.09±0.07)、(1.09±0.09)比(0.79±0.06),P<0.05]显著高于模型组。结论 何氏补肾益气活血方通过降低ACA滴度,激活JAK-STAT3信号通路并促进细胞增殖,有助于改善ACA阳性血栓前状态RSA小鼠的胚胎着床环境以及妊娠结局,为临床防治提供实验依据。
英文摘要:
      Objective To explore the mechanism of Heshi Bushen Yiqi Huoxue Decoction on regulating status of maternal-fetal interface in RSA mice suffering ACA positive prethrombus status based on JAK ∕ STAT3 signaling pathway. Methods Establishing RSA mice model suffering ACA positive prethrombus with humanβ2-GPⅠ as derivant. Fifty completed the modeling process mice were divided into five groups . Specifically refers to blank control group (treated with normal saline), model control group (treated with β2-GPⅠ), positive control group (treated with aspirin), and Heshi Bushen Yiqi Huoxue decoction of low and high dose groups. Pregnancy mice received intragastric administration of the different test compound daily for two weeks form the first day of conception observed. Mice were euthanized at 15th day of their pregnancy to calculate the embryo resorption rate, and the blood and tissue samples were collected to analyse the ACA levels in peripheral blood by means of ELISA. The expression of JAK, GP130, p-STAT3, and PCNA in placental and decidual tissues was analyzed by immunohistochemistry, whereas STAT3 and p-STAT3 protein levels were evaluated by Western blot analysis. Results Compared with the model group, the aspirin control, low-dose Chinese medicine, and high-dose Chinese medicine groups demonstrated: Significantly lower embryo loss rates [(24.49±11.17)%, (16.18±11.92)%, and (15.94±8.01)% vs. (42.53±15.12)%, respectively; P<0.05]; Markedly reduced serum ACA titers [(93.16±6.75) pg/mL, (92.31±5.22) pg/mL, and (81.60±5.18) pg/mL vs. (419.51±94.00) pg/mL; P<0.05]; and Significantly increased protein expression at the maternal-fetal interface: placental JAK [(1.44±0.53), (1.43±0.50), (1.51±0.35) vs. (0.21±0.31); P<0.05], placental p-STAT3 [(1.83±0.41), (2.00±0.63), (2.00±0.71) vs. (0.20±0.45); P<0.05], decidual p-STAT3 [(2.50±0.55), (2.67±0.52), (2.80±0.84) vs. (1.39±0.99); P<0.05], placental PCNA [(2.88±0.36), (3.00±0.58), (2.91±0.68) vs. (3.50±0.59); P<0.05], decidual PCNA [(1.07±0.09), (1.09±0.07), (1.09±0.09) vs. (0.79±0.06); P<0.05]. Conclusion Heshi Bushen Yiqi Huoxue Decoction can reduce ACA titers, activate the JAK-STAT3 signaling pathway, and promote cell proliferation. These effects improve the embryo implantation environment and pregnancy outcomes in ACA-positive mice, providing experimental evidence for clinical prevention and treatment.
查看全文  查看/发表评论  下载PDF阅读器
关闭